ArticleFrontiers in medicine2025
Clinical effect of unilateral biportal minimally invasive surgery in the treatment of patients with spinal degenerative diseases based on intelligent multimodal reconstruction technology.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the effect of unilateral biportal minimally invasive surgery in the treatment of patients with spinal degenerative diseases based on intelligent multimodal reconstruction technology. Methods: A total of 100 patients with spinal degenerative diseases treated with unilateral biportal endoscopy during 2023-2024 in Orthopedics Center of our hospital were selected as research objects. Patients using intelligent multi-modal reconstruction technology were included as observation group, and patients not using intelligent multi-modal reconstruction technology were included as control group. The length of hospital stay, operation time, intraoperative blood loss, postoperative drainage volume, total blood loss, hidden blood loss, hematocrit, hemoglobin level, incidence of complications, degree of pain and lumbar function were assessed. Results: Compared to the control group, the observation group had shorter operation time, shorter length of hospital stay, less intraoperative blood loss, less postoperative drainage volume, less total blood loss, less hidden blood loss, higher hematocrit and higher hemoglobin level ( Conclusion: Unilateral biportal minimally invasive surgery based on intelligent multimodal reconstruction technology can accelerate the body recovery, reduce the incidence of complications, reduce the degree of pain and improve the lumbar function in the treatment of patients with spinal degenerative diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.